465
Views
14
CrossRef citations to date
0
Altmetric
Case Report

Treatment of early-stage erythematotelangiectatic rosacea with a Q-switched 595-nm Nd:YAG laser

, &
Pages 139-142 | Received 31 Mar 2014, Accepted 11 Dec 2014, Published online: 29 Jan 2015

References

  • Plewig G, Kligman AM. Acne and rosacea. 3rd ed. Berlin: Springer; 2000. p. 455–502.
  • Bernstein EF, Kligman A. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med. 2008;40:233–239.
  • Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–341.
  • Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51:499–512.
  • Goldberg DJ, Marcus J. The use of the frequency-doubled Q-switched Nd:YAG laser in the treatment of small cutaneous vascular lesions. Dermatol Surg. 1996;22:841–844.
  • Erceg A, de Jong EM, van de Kerkhof PC, Seyger MM. The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol. 2013; 69:609–615.
  • Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther. 2005;18:267–281.
  • Kim BW, Lee MH, Chang SE, Yun WJ, Won CH, Lee MW, et al. Clinical efficacy of the dual-pulsed Q-switched neodymium:yttrium-aluminum-garnet laser: comparison with conservative mode. J Cosmet Laser Ther. 2013;15:340–341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.